Cargando…

CMTM6 significantly relates to PD-L1 and predicts the prognosis of gastric cancer patients

BACKGROUND: The CKLF-like MARVEL transmembrane domain containing 6 (CMTM6) is a key regulator of the programed death receptor ligand-1 (PD-L1) protein. However, the usefulness of CMTM6 expression as a prognostic indicator and the relationship between CMTM6 and PD-L1 expression in gastric cancer (GC)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Xin, Chen, Ling, Gu, Chuan, Sun, Qiaoli, Li, Jia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	PeerJ Inc. 2020
Materias:	Bioinformatics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7439957/ https://www.ncbi.nlm.nih.gov/pubmed/32874775 http://dx.doi.org/10.7717/peerj.9536

Ejemplares similares

CMTM6 is highly expressed in lung adenocarcinoma and can be used as a biomarker of a poor diagnosis
por: Jia, Daqi, et al.
Publicado: (2023)

Identification of CMTM6 and CMTM4 as PD-L1 protein regulators
por: Mezzadra, Riccardo, et al.
Publicado: (2017)

Analysis of CMTM6 and CMTM4 expression as potential regulators of the PD-L1 protein and its association with prognosis in glioma cancer
por: Xue, Hui, et al.
Publicado: (2022)

CMTM6 and CMTM4 as two novel regulators of PD-L1 modulate the tumor microenvironment
por: Zhang, Tong, et al.
Publicado: (2022)

Expression and Clinical Significance of CMTM6 and PD-L1 in Triple-Negative Breast Cancer
por: Shi, Shuai, et al.
Publicado: (2022)

Coexpression of CMTM6 and PD-L1 as a predictor of poor prognosis in macrotrabecular-massive hepatocellular carcinoma
por: Liu, Li-Li, et al.
Publicado: (2020)

Expression Analysis of Canine CMTM6 and CMTM4 as Potential Regulators of the PD-L1 Protein in Canine Cancers
por: Takeuchi, Hiroto, et al.
Publicado: (2020)

CMTM6 and CMTM7: New leads for PD‐L1 regulation in breast cancer cells undergoing EMT
por: Xiao, Malina, et al.
Publicado: (2022)

The m(6)A-related gene signature for predicting the prognosis of breast cancer
por: Zhong, Shanliang, et al.
Publicado: (2021)

The association of CMTM6 expression with prognosis and PD-L1 expression in triple-negative breast cancer
por: Tian, Yiping, et al.
Publicado: (2021)

CMTM6, the newly identified PD-L1 regulator, correlates with PD-L1 expression in lung cancers
por: Gao, Feng, et al.
Publicado: (2019)

A DCS-related lncRNA signature predicts the prognosis and chemotherapeutic response of patients with gastric cancer
por: Zhang, Yang, et al.
Publicado: (2022)

Co-expression of CMTM6 and PD-L1: a novel prognostic indicator of gastric cancer
por: Zhang, Chao, et al.
Publicado: (2021)

CMTM6 and PD-L1 coexpression is associated with an active immune microenvironment and a favorable prognosis in colorectal cancer
por: Peng, Qi-Hua, et al.
Publicado: (2021)

Epithelial to Mesenchymal Transition Regulates Surface PD-L1 via CMTM6 and CMTM7 Induction in Breast Cancer
por: Xiao, Malina, et al.
Publicado: (2021)

Associations of individual and joint expressions of ERCC6 and ERCC8 with clinicopathological parameters and prognosis of gastric cancer
por: Chen, Jing, et al.
Publicado: (2021)

Identification of m6A methyltransferase-related lncRNA signature for predicting immunotherapy and prognosis in patients with hepatocellular carcinoma
por: Li, Lili, et al.
Publicado: (2021)

Co-Expression with Membrane CMTM6/4 on Tumor Epithelium Enhances the Prediction Value of PD-L1 on Anti-PD-1/L1 Therapeutic Efficacy in Gastric Adenocarcinoma
por: Wang, Ziqi, et al.
Publicado: (2021)

Identification and validation of key genes associated with pathogenesis and prognosis of gastric cancer
por: Li, Ai, et al.
Publicado: (2023)

Development and clinical validation of a 3-miRNA signature to predict prognosis of gastric cancer
por: Qi, Wenqian, et al.
Publicado: (2021)

Novel pyroptosis-associated genes signature for predicting the prognosis of sarcoma and validation
por: Wen, Hao, et al.
Publicado: (2022)

A cholesterogenic gene signature for predicting the prognosis of young breast cancer patients
por: Li, Xiaoping, et al.
Publicado: (2022)

Identification of potential biomarkers and their clinical significance in gastric cancer using bioinformatics analysis methods
por: Liu, Jie, et al.
Publicado: (2020)

Autophagy-related genes prognosis signature as potential predictive markers for immunotherapy in hepatocellular carcinoma
por: Mao, Deli, et al.
Publicado: (2020)

CMTM6 overexpression is associated with molecular and clinical characteristics of malignancy and predicts poor prognosis in gliomas
por: Guan, Xiudong, et al.
Publicado: (2018)

Identification of Vitamin D-related gene signature to predict colorectal cancer prognosis
por: Bu, Luping, et al.
Publicado: (2021)

A glycolysis-related gene pairs signature predicts prognosis in patients with hepatocellular carcinoma
por: Zhou, Weige, et al.
Publicado: (2020)

Significant correlation between HSPA4 and prognosis and immune regulation in hepatocellular carcinoma
por: Shang, Bing-Bing, et al.
Publicado: (2021)

Development of a 5-mRNAsi-related gene signature to predict the prognosis of colon adenocarcinoma
por: Huang, Haifu, et al.
Publicado: (2023)

Immune activity score to assess the prognosis, immunotherapy and chemotherapy response in gastric cancer and experimental validation
por: Wu, Xuan, et al.
Publicado: (2023)

CELSR3 mRNA expression is increased in hepatocellular carcinoma and indicates poor prognosis
por: Gu, Xuefeng, et al.
Publicado: (2019)

An eight-mRNA signature predicts the prognosis of patients with bladder urothelial carcinoma
por: Zhu, Rui, et al.
Publicado: (2019)

Identification of an extracellular vesicle-related gene signature in the prediction of pancreatic cancer clinical prognosis
por: Xu, Dafeng, et al.
Publicado: (2020)

Investigating the significance of tumor-infiltrating immune cells for the prognosis of lung squamous cell carcinoma
por: Zhu, Yueyan, et al.
Publicado: (2019)

Immune‐relatedlncRNAs can predict the prognosis of acute myeloid leukemia
por: Li, Ran, et al.
Publicado: (2021)

A robust signature of immune‐related long non‐coding RNA to predict the prognosis of bladder cancer
por: Lai, Cong, et al.
Publicado: (2021)

A gene expression-based risk model reveals prognosis of gastric cancer
por: Deng, Xiaorong, et al.
Publicado: (2018)

Identification of pivotal genes associated with the prognosis of gastric carcinoma through integrated analysis
por: Ma, Zhenchao, et al.
Publicado: (2021)

The role of m6A-related genes in the prognosis and immune microenvironment of pancreatic adenocarcinoma
por: Tang, Rong, et al.
Publicado: (2020)

Long non-coding RNA polymorphisms on 8q24 are associated with the prognosis of gastric cancer in a Chinese population
por: Zhang, Yangyu, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jk91ljt1msmeoa4rh02o6e87be